Analysis of the optimal vaccination age for dengue in Brazil with a tetravalent dengue vaccine
From MaRDI portal
Publication:680423
DOI10.1016/J.MBS.2017.09.004zbMath1382.92241OpenAlexW2756226472WikidataQ46302508 ScholiaQ46302508MaRDI QIDQ680423
Sandra B. Maier, Marcos Amaku, David Greenhalgh, Marcelo N. Burattini, Xiao Huang, Eduardo Massad
Publication date: 23 January 2018
Published in: Mathematical Biosciences (Search for Journal in Brave)
Full work available at URL: https://researchonline.lshtm.ac.uk/id/eprint/4433698/1/Analysis%20of%20the%20Optimal%20Vaccination_GREEN%20AAM.pdf
mortalityvaccinationdenguerisk functionage-structured modelserotypehospitalisationoptimal vaccination age
Related Items (9)
Vaccination and vector control effect on dengue virus transmission dynamics: modelling and simulation ⋮ Cross immunity protection and antibody-dependent enhancement in a distributed delay dynamic model ⋮ Optimal dengue vaccination strategies of seropositive individuals ⋮ Optimal vaccine allocation for the control of sexually transmitted infections ⋮ Optimal control strategies for dengue transmission in Pakistan ⋮ Disease persistence and serotype coexistence: an expected feature of human mobility ⋮ Estimation of the expected number of cases of microcephaly in Brazil as a result of zika ⋮ Modelling the effect of a novel autodissemination trap on the spread of dengue in Shah Alam and Malaysia ⋮ An optimal control problem for dengue transmission model with \textit{Wolbachia} and vaccination
Cites Work
- A two-age-classes dengue transmission model
- Backward bifurcations in dengue transmission dynamics
- Optimal ages of vaccination for measles
- Analysis of a dengue disease transmission model
- Coexistence of different serotypes of dengue virus
- Vaccinations in disease models with antibody-dependent enhancement
- Dengue fever: Mathematical modelling and computer simulation
- The potential impact of vaccination on the dynamics of dengue infections
This page was built for publication: Analysis of the optimal vaccination age for dengue in Brazil with a tetravalent dengue vaccine
